| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 44 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 30 |
| 2 | TACROLIMUS OINTMENT 0.1% | 30 |
| 3 | PREDNISONE | 28 |
| 4 | MYCOPHENOLATE MOFETIL | 26 |
| 5 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 26 |
| 6 | VALGANCICLOVIR | 16 |
| 7 | VALGANCICLOVIR HYDROCHLORIDE | 16 |
| 8 | CYCLOSPORINE | 15 |
| 9 | FUROSEMIDE | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CLOTRIMAZOLE1% CLOTRIMAZOLE | 1 | 0.0182 |
| 1 | SODIUM PHOSPHATE, DIBASIC AND SODIUM PHOSPHATE, MONOBASIC | 1 | 0.0122 |
| 2 | ASCORBIC ACID, THIAMINE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE, FOLIC ACID, COBALAMIN, BIOTIN, PANTOTHENIC ACID | 1 | 0.0016 |
| 3 | BELATACEPT | 7 | 0.0015 |
| 4 | CASPOFUNGIN ACETATE | 2 | 0.0013 |
| 5 | VANDETANIB | 2 | 0.0011 |
| 6 | ERTUGLIFLOZIN | 1 | 0.0009 |
| 7 | VALGANCICLOVIR | 16 | 0.0008 |
| 8 | DEFLAZACORT | 2 | 0.0008 |
| 9 | BASILIXIMAB | 9 | 0.0008 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Selective T Cell Costimulation Blocker [EPC] | 7 | 0.0015 |
| 1 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 16 | 0.0007 |
| 2 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 3 | Antihypoglycemic Agent [EPC] | 2 | 0.0005 |
| 4 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 5 | Osmotic Diuretic [EPC] | 2 | 0.0004 |
| 6 | Antimetabolite Immunosuppressant [EPC] | 6 | 0.0003 |
| 7 | Sulfonamide Antibacterial [EPC] | 1 | 0.0003 |
| 8 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 2 | 0.0002 |
| 9 | Antiseptic [EPC] | 1 | 0.0002 |